CAC · Class II · 21 CFR 868.5830

FDA Product Code CAC: Apparatus, Autotransfusion

Recovering the patient's own shed blood reduces transfusion requirements during surgery. FDA product code CAC covers autotransfusion apparatus used in operative and post-operative blood recovery.

These systems collect, filter, wash, and reinfuse the patient's own shed blood during cardiac, vascular, and orthopedic surgery. Autotransfusion reduces allogeneic blood exposure and its associated risks, including transfusion reactions and infection transmission.

CAC devices are Class II medical devices, regulated under 21 CFR 868.5830 and reviewed by the FDA Hematology panel.

Leading manufacturers include Boehringer Laboratories, Deknatel, Inc. and Shiley, Inc..

195
Total
195
Cleared
153d
Avg days
1977
Since
Declining activity - 1 submissions in the last 2 years vs 5 in the prior period
Review times improving: avg 106d recently vs 154d historically

FDA 510(k) Cleared Apparatus, Autotransfusion Devices (Product Code CAC)

195 devices
1–24 of 195
Cleared Aug 16, 2024
XTRA Collection sets
K241236
Sorin Group Italia S.R.L.
Cardiovascular · 106d
Cleared May 14, 2024
Aventus Clot Management System
K240426
Inquis Medical
Cardiovascular · 91d
Cleared Apr 29, 2024
XTRA Autotransfusion System (with XTRA Bowl sets)
K240584
Sorin Group Italia S.R.L.
Cardiovascular · 59d
Cleared Jul 14, 2023
FlowSaver Blood Return System (80-101)
K231782
Inari Medical, Inc.
Cardiovascular · 28d
Cleared Feb 17, 2023
FlowSaver Blood Return System
K221483
Inari Medical, Inc.
Cardiovascular · 270d
Cleared Nov 15, 2022
Haemonetics Cell Saver Elite/Elite+ Autotransfusion System (CSE-E-US/CSE-EW-US)
K221722
Haemonetics Corporation
Cardiovascular · 154d
Cleared Sep 03, 2021
Auto transfusion (ATS) Chest Drains: Ocean Water Seal Chest Drain, Oasis Dry Suction Water Seal Chest Drain, Express Dry Seal Chest Drain
K201305
Atrium Medical Corporation
Cardiovascular · 476d
Cleared Jul 29, 2021
Hemafuse System
K210862
Sisu Global Health
Cardiovascular · 128d
Cleared Jul 22, 2021
FlowSaver Blood Filter
K210176
Inari Medical
Cardiovascular · 181d
Cleared Feb 11, 2021
CATSmart, Automated Blood Processing Autotransfusion System
K210089
Fresenius Kabi AG
Cardiovascular · 29d
Cleared Jun 01, 2020
ProCell Surgical Sponge-Blood Recovery Unit
K193361
Procell Surgical, Inc.
Cardiovascular · 180d
Cleared Sep 27, 2019
CATSmart
K192368
Fresenius Kabi AG
Cardiovascular · 28d
Cleared Dec 10, 2018
CATSmart
K180831
Fresenius Kabi AG
Cardiovascular · 255d
Cleared Aug 22, 2018
autoLog IQ Autotransfusion System
K181954
Medtronic Perfusion Systems
Cardiovascular · 30d
Cleared Oct 23, 2014
PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AND AUTOTRANSFUSION SYSTEM
K140205
Teleflexmedical, Inc.
Anesthesiology · 269d
Cleared Oct 21, 2014
PLEUR-EVAC PLUS CONTINUOUS REINFUSION AND AUTOTRANSFUSION SYSTEM
K140197
Teleflexmedical, Inc.
Anesthesiology · 267d
Cleared Feb 12, 2013
PLEUR-EVAC SAHARA PLUS CONTINUOUS REINFUSION AUTOTRANSFUSION SYSTEM
K130043
Teleflexmedical, Inc.
Anesthesiology · 35d
Cleared Sep 06, 2011
XTRA
K112245
Sorin Group Italia S.R.L.
Anesthesiology · 33d
Cleared Apr 07, 2011
XVAC
K110782
Sorin Group Italia S.R.L.
Anesthesiology · 17d
Cleared Nov 23, 2010
PREASSEMBLED SURGICAL WASH SET
K103202
Sorin Group Italia S.R.L.
Anesthesiology · 22d
Cleared Oct 05, 2010
XTRA AUTOTRANSFUSION SYSTEM
K101586
Sorin Group Italia S.R.L.
Anesthesiology · 120d
Cleared Mar 22, 2010
AUTOLOG AUTOTRANSFUSION SYSTEM
K093535
Medtronic, Inc.
Anesthesiology · 126d
Cleared Dec 08, 2004
EXPRESS AND OASIS CHEST DRAIN
K043140
Atrium Medical Corp.
Anesthesiology · 23d
Cleared Oct 14, 2004
HEMOVAC BLOOD REINFUSION SYSTEM
K041525
Zimmer, Inc.
Anesthesiology · 128d

About Product Code CAC - Regulatory Context

510(k) Submission Activity

195 total 510(k) submissions under product code CAC since 1977, with 195 receiving FDA clearance (average review time: 153 days).

Submission volume has declined in recent years - 1 submissions in the last 24 months compared to 5 in the prior period.

FDA 510(k) Review Time - CAC Product Code

Recent submissions under CAC have taken an average of 106 days to reach a decision - down from 154 days historically, suggesting improved FDA processing for this classification.

CAC devices are reviewed by the Anesthesiology panel. Browse all Anesthesiology devices →